Location History:
- Derby, CT (US) (2006 - 2014)
- Guilford, CT (US) (2014)
Company Filing History:
Years Active: 2006-2014
Title: Innovations by Inventor Bo Chen in Blood Oxygenation Monitoring
Introduction
Bo Chen, an inventive mind based in Derby, CT, has made significant contributions to the field of biomedical engineering through his innovative patents. With a total of four patents to his name, Chen's work primarily focuses on methods for non-invasive monitoring of blood oxygenation, highlighting the importance of real-time health monitoring technologies in clinical settings.
Latest Patents
Among his latest patents, Bo Chen introduced a groundbreaking method for spectrophotometric blood oxygenation monitoring. This innovation utilizes a near-infrared spectrophotometric (NIRS) sensor designed to non-invasively determine blood oxygen levels within a subject's tissue. The system is capable of transmitting a light signal into the tissue and sensing the light once it has traversed through it, either via transmittance or reflectance.
Another notable patent from Chen is centered around indicators for a spectrophotometric system, specifically a cerebral oximeter. This system features a sensor and a monitor portion where a processor runs algorithms to assess the detected light and compute oxygen concentration values. The monitor's display presents these values in various formats, including color-coded graphs, which serve to alert users about potential risks to brain health. Additionally, the system simplifies information display by focusing on clinically relevant sensor values to facilitate quicker interpretation by healthcare professionals.
Career Highlights
Bo Chen’s career has been marked by his role at Cas Medical Systems, Inc., where he has leveraged his expertise in creating important health monitoring technologies. His patents have not only showcased his innovative capacity but have also played a pivotal role in enhancing patient care and monitoring outcomes in clinical environments.
Collaborations
Working alongside industry peers such as Paul B Benni and Andrew Kersey, Chen has collaborated with talented individuals to push the boundaries of biomedical research and technology. These collaborations have been instrumental in refining and advancing the applications of his patented technologies, contributing to a greater understanding of oxygenation monitoring.
Conclusion
Bo Chen continues to be a notable figure in the field of biomedical innovations, particularly in non-invasive blood oxygenation monitoring technologies. His contributions through patents demonstrate a commitment to improving healthcare and the efficacy of clinical monitoring procedures, establishing him as a pivotal inventor in this crucial area of research.